Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients

SIMPLE SUMMARY: In our research, we analyzed the CT scans of 322 advanced lung cancer patients over time to see how long they might remain disease-free after undergoing a specific treatment called EGFR-TKI. By integrating the patterns from these scans with other medical data, such as gene mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting-Wei, Chao, Heng-Sheng, Chiu, Hwa-Yen, Lin, Yi-Hui, Chen, Hung-Chun, Lu, Chia-Feng, Liao, Chien-Yi, Lee, Yen, Shiao, Tsu-Hui, Chen, Yuh-Min, Huang, Jing-Wen, Wu, Yu-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647242/
https://www.ncbi.nlm.nih.gov/pubmed/37958300
http://dx.doi.org/10.3390/cancers15215125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647242/
https://www.ncbi.nlm.nih.gov/pubmed/37958300
http://dx.doi.org/10.3390/cancers15215125

Ejemplares similares